Objectives
After participating in this educational activity, attendees should be able to:
1|Identify biological and clinical significance of pancreatic precursor lesions in the progression to invasive cancer.
2|Discuss recent advances in 3D genomic mapping and their contribution to understanding pancreatic precursor lesions and their progression to invasive cancer.
3|Recognize recent advances in the tumor immune microenvironment in precursor lesions and their influence on pancreatic cancer development.
Presenter(s):
Laura DeLong Wood, MD, PhD
Associate Professor of Pathology, Oncology, & Medicine
Director, Gastrointestinal & Liver Pathology
Deputy Director, Sol Goldman Pancreatic Cancer Research Center
Associate Director, MD/PhD Program
Co-Leader, Cancer Invasion & Metastasis Program
Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins University School of Medicine
Kevin Tony Jamouss, MD
Internal Medicine Resident Physician, UMass Chan Medical School-Baystate
Department of Medicine, Baystate Health
| Name | Role | Financial Relationship Disclosures | Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation? | |
|---|---|---|---|---|
| Laura Delong Wood, MD, PhD | Speaker | No relevant relationships with ineligible companies to disclose | no | |
| Kevin Jamouss, MD | Speaker |
| no |
Session date:
09/10/2025 - 8:00am to 9:00am EDT
Location:
Baystate Medical Center
759 Chestnut Street
Webinar only
Springfield, MA
01199
United States
See map: Google Maps
Add to calendar:
- 1.00 AAPA Category 1 CME creditBaystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PA’s should only claim credit commensurate with the extent of their participation.
- 1.00 ACPE Contact Hours
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC Contact Hours
- 1.00 IPCE Credit Hour(s)
Facebook
X
LinkedIn
Forward